New eczema drug shows promise in large chinese trial
NCT ID NCT06173284
First seen Nov 20, 2025 · Last updated May 11, 2026 · Updated 26 times
Summary
This study tested a new medicine called 611 in 519 Chinese adults with moderate-to-severe atopic dermatitis (eczema). The drug works by blocking a protein involved in inflammation. Participants received either 611 or a placebo, and researchers measured how much their skin improved after 16 weeks. The goal was to see if 611 could safely reduce eczema severity and itching.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATITIS, ATOPIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
-
Dermatology Hospital of Jiangxi Province
Nanchang, Jiangxi, 330200, China
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
-
The Fourth Affiliated Hospital Zhejiang University School of Medicine
Jinhua, Zhejiang, 322000, China
Conditions
Explore the condition pages connected to this study.